Clinical Trial: A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
Study Status: Completed
Recruit Status: RECRUITING
Condition: Herpes Zoster
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (LZ901) in Subjects Aged 50 to 70 Years Inclusive
Brief Summary:
This clinical trial is to study the safety and tolerability of a recombinant herpes zoster vaccine (LZ901) and sponsored by Beijing Luzhu Biotechnology Co., Ltd.It is a phase I, randomized, double-blind, placebo-controlled, dose escalation study in healthy people aged 50 to 70 years inclusive.The study is to protect adults against shingles (herpes zoster / varicella zoster virus(VZV)).There will be about 66 participators who will receive two-dose injection at the upper arm.LZ901 vaccine is made up of a…
Read more